A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC)

Overview of attention for article published in International Journal of Gynecological Cancer, May 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,221 followers.

Open Access UCL Research: A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC) https://t.co/Z2VLhIy29s

A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC) https://t.co/UGOpZOmkQI

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.